Risedronate |
Actonel; risedronate sodium |
Risedronate Systematic (IUPAC) name (1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid Identifiers CAS number 105462-24-6 ATC code M05BA07 PubChem 5245 DrugBank APRD00410 Chemical data Formula C7H11NO7P2 Mol. weight 283.112 g/mol Pharmacokinetic data Bioavailability 0.63% Protein binding ~24% Metabolism None Half life 1.5 hours Excretion Renal and fecal Therapeutic considerations Pregnancy cat. B3(AU) C(US) Legal status POM(UK) â ...
Wikipedia - [full article]
Resources
- Actonel (Drug Digest)
- Actonel Consumer Information (U.S. Food and Drug Administration)
Risedronate News Headlines
- Actonel prevents fractures better than Fosamax
Reuters - Wed, 22 Nov 2006 08:45 EST
- New Study Shows Actonel Almost Halves The Risk Of Hip Fractures Compared To Alendronate
MedicalNewsToday - Fri, 24 Nov 2006 11:00 EST
- Higher Persistency Rates Seen With FOSAMAX® Once Weekly Therapies Compared To Other Weekly And Monthly Oral Bisphosphonates
MedicalNewsToday - Mon, 25 Sep 2006 07:00 EST
- Women With Osteoporosis More Likely To Stay On Once-Monthly Oral Bonviva® Than On A Once-Weekly Treatment Regimen
MedicalNewsToday - Mon, 18 Sep 2006 04:00 EST
- Osteoporosis Treatment Now Approved In Europe And US For Men
MedicalNewsToday - Tue, 22 Aug 2006 04:00 EST
- The U.S. Food And Drug Administration Approves Actonel For Broader Use In Men With Osteoporosis
MedicalNewsToday - Tue, 15 Aug 2006 07:00 EST

Not Signed In -

